National Institute of Allergy and Infectious Diseases



	Advanced Search

News & Events
News Releases
Qs & As
Media Inquiries
Events & Calendars
Calendars
Commemorative Days
HIV Vaccine Awareness Day
Meetings and Lectures
US-Japan Viral Immunology Symposium
Vaccine Research Seminars
NIAID in the News
Resources

Vaccines for Viral Infections in Developing Countries

Agenda

Thursday, July 27, 2006

8:50 AM	Opening Remarks Diane Griffin, Johns Hopkins University, USA Harry Greenberg, Stanford University, USA
9:00 AM	Overview and Major Issues for Assessment of Disease Burden of Viral Diseases in Asia (PDF) Hitoshi Oshitani, Tohoku University, Japan

Rotavirus Session

9:45 AM	Epidemiology Of Rotavirus Infection And The Need For A Vaccine In Asia (PDF) Tony Nelson, The Chinese University of Hong Kong, China
10:15 AM	Development and Implementation of Vaccine Made in the Third World (PDF) R. Bhan, New Delhi, India
10:45 AM	Break
11:00 AM	Outlook for the Implementation of a Human-Bovine (UK) Rotavirus Reassortant Vaccine (PDF) Al Kapikian, NIH, USA
11:30 AM	Development and Commercial Manufacturing Challenges for Live Attenuated Rotavirus Vaccines (PDF) W. Wainwright, Path and NIH, USA
12:00 PM	Phase III Clinical Results of Rotavirus Vaccine Trials and Efforts to Accelerate Introduction to the Developing World (PDF) John Boslego, Path, USA
12:30 PM	Lunch

Human Papillomavirus Session

1:30 PM	Human Papillomavirus Vaccination for Cervical Cancer Prevention (PDF) Patti Gravitt, Johns Hopkins University, USA
2:00 PM	Issues Regarding Marketing and Distribution of Vaccines in Developing Countries (PDF) Elaine Esber, Merck, USA
2:30 PM	Development of Human Papillomavirus Vaccine Against a Broader Spectrum of Oncogenic Types (PDF) Tadahito Kanda, Japan

Rabiesvirus Session

3:00 PM	Rabies Epidemiology, Disease Burden and Vaccine Utilization in Asia (PDF) Elizabeth Miranda, Phillipines
3:30 PM	Break
3:45 PM	Current Vaccines and Their Availability in China (PDF) Zhen Fu, University of Georgia, USA
4:15 PM	Control of Rabies in Asia Requires Quality Biologicals and the Motivation to Use Them Appropriately (PDF) Henry Wilde, Thai Red Cross
4:45 PM	Adjourn
6:30- 8:30 PM	Reception

Friday, July 28, 2006

Japanese Encephalitis Session

9:00 AM	Strategy for Introduction of JE Vaccine Into Routine Immunization (PDF) Julie Jacobson, Path, USA
9:30 AM	Disease Burden Due to Japanese Encephalitis (JE) and Cost-Effectiveness of JE Immunization in Asia (PDF) Zhi-Yi Xu, IVI, Seoul
10:00 AM	Continued Transmission and Need for Booster Doses in An Endemic Country (PDF) Eiji Konishi, Kobe University, Japan
10:30 AM	Break
10:45 AM	Immunological Surrogates for Japanese Encephalitis Vaccine-Induced Protection (PDF) Ichiro Kurane, NIH Japan
11:15 AM	Developing a New JE Vaccine–Switch the Mouse Brain to the Vero Cell (PDF) Shigeharu Ueda, BIKEN Foundation, Japan
11:45 AM	Inactivated SA14-14-2 (PDF) Erich Tauber, Intercell, AG
12:15 PM	Lunch
1:30 PM	Safety and Efficacy of Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 in Human Vaccination (PDF) Yu Yongxin, NICBP, Beijing
2:00 PM	Chimerivax^TM – A Platform Technology for Flavivirus Vaccine Development – Status of a New Vaccine Against Japanese Encephalitis (PDF) Niranjan Kanesa-thasan, Acambis, USA

Influenza Session

2:30 PM	Emergence and Continuing Evolution of H5N1 Influenza (PDF) Robert Webster, St. Jude Hospital, USA
3:00 PM	Vaccine Development for Pandemic and Seasonal Influenza (PDF) John Treanor, University of Rochester Medical Center, USA
3:30 PM	Break
3:45 PM	Influenza in Asia (PDF) Hiroshi Suzuki, Niigata University, Japan
4:15 PM	Influenza Virus Patterns in Asia (PDF) Mark Steinhoff, Johns Hopkins University, USA
4:45 PM	Development Of Human Influenza H5N1 Vaccines In Japan: Research And Clinical Trials (PDF) Masato Tashiro, National Institute of Infectious Diseases, Japan
5:15 PM	Closing Remarks Akira Oya, National Institute of Infectious Diseases, Japan

Participant List (PDF)